Previous Section
Clinical Trials
61. A Phase 2 study of perifosine in advanced or metastatic breast cancer.
- Author
- Leighl NB; Dent S; Clemons M; Vandenberg TA; Tozer R; Warr DG; Crump RM; Hedley D; Pond GR; Dancey JE; Moore MJ;
- Institution
- Medical Oncology, Princess Margaret Hospital/University Health Network, Toronto, ON, Canada. Natasha.Leighl@uhn.on.ca
- Journal
- Breast Cancer Res Treat. 2008 Mar;108(1):87-92. Epub 2007 Apr 26.
- Abstract URL
- Click here to view abstract
62. A phase II study of trastuzumab and capecitabine for patients with HER2-overexpressing metastatic breast cancer: Japan Breast Cancer Research Network (JBCRN) 00 Trial.
- Author
- Yamamoto D; Iwase S; Kitamura K; Odagiri H; Yamamoto C; Nagumo Y;
- Institution
- Department of Surgery, Kansai Medical University Hirakata Hospital, Hirakata, Osaka 573-1191, Japan. yamamotd@hirakata.kmu.ac.jp
- Journal
- Cancer Chemother Pharmacol. 2008 Mar;61(3):509-14. Epub 2007 May 22.
- Abstract URL
- Click here to view abstract
63. Cancer risk among Los Angeles women with cosmetic breast implants.
- Author
- Deapen DM; Hirsch EM; Brody GS;
- Institution
- Department of Preventive Medicine, Division of Plastic Surgery, and Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. ddeapen@usc.edu
- Journal
- Plast Reconstr Surg. 2007 Jun;119(7):1987-92.
- Abstract URL
- Click here to view abstract
64. Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study.
- Author
- Burstein HJ; Keshaviah A; Baron AD; Hart RD; Lambert-Falls R; Marcom PK; Gelman R; Winer EP;
- Institution
- Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. hburstein@partners.org
- Journal
- Cancer. 2007 Sep 1;110(5):965-72.
- Abstract URL
- Click here to view abstract
65. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial.
- Author
- Del Bianco P; Zavagno G; Burelli P; Scalco G; Barutta L; Carraro P; Pietrarota P; Meneghini G; Morbin T; Tacchetti G; Pecoraro P; Belardinelli V; De Salvo GL;
- Institution
- Clinical Trials and Biostatistics Unit, Istituto Oncologico Veneto - IRCCS, Via Gattamelata 64, Padova, Italy.
- Journal
- Eur J Surg Oncol. 2008 May;34(5):508-13. Epub 2007 Jul 5.
- Abstract URL
- Click here to view abstract
66. A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline.
- Author
- Hong RL; Lin CH; Chao TY; Kao WY; Wang CH; Hsieh RK; Hwang WS;
- Institution
- Department of Oncology, National Taiwan University Hospital, No 7, Chung-Shan South Rd, Taipei 10016, Taiwan. rlhong@ha.mc.ntu.edu.tw
- Journal
- Cancer Chemother Pharmacol. 2008 Apr;61(5):847-53. Epub 2007 Jul 4.
- Abstract URL
- Click here to view abstract
67. Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer.
- Author
- Semiglazov VF; Semiglazov VV; Dashyan GA; Ziltsova EK; Ivanov VG; Bozhok AA; Melnikova OA; Paltuev RM; Kletzel A; Berstein LM;
- Institution
- N. N. Petrov Research Institute of Oncology, St. Petersburg, Russia. ssemiglazov@mail.ru
- Journal
- Cancer. 2007 Jul 15;110(2):244-54.
- Abstract URL
- Click here to view abstract
68. Phase III randomized multicenter study on the effects of adjuvant CMF in patients with node-negative, rapidly proliferating breast cancer: twelve-year results and retrospective subgroup analysis.
- Author
- Amadori D; Nanni O; Volpi A; Casadei Giunchi D; Marangolo M; Livi L; Ravaioli A; Rossi AP; Gambi A; Luzi Fedeli S; Perroni D; Scarpi E; Becciolini A; Silvestrini R;
- Institution
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Via Maroncelli 34/36, 47014 Meldola, Italy. segronco@ausl.fo.it
- Journal
- Breast Cancer Res Treat. 2008 Mar;108(2):259-64. Epub 2007 May 26.
- Abstract URL
- Click here to view abstract
69. Effects of a combined aerobic and resistance exercise program in breast cancer survivors: a randomized controlled trial.
- Author
- Milne HM; Wallman KE; Gordon S; Courneya KS;
- Institution
- School of Human Movement and Exercise Science, The University of Western Australia, 35 Stirling Highway, Crawley, WA 6009, Australia. helenmilne@ekit.com
- Journal
- Breast Cancer Res Treat. 2008 Mar;108(2):279-88. Epub 2007 May 26.
- Abstract URL
- Click here to view abstract
70. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients.
- Author
- Langer I; Guller U; Berclaz G; Koechli OR; Schaer G; Fehr MK; Hess T; Oertli D; Bronz L; Schnarwyler B; Wight E; Uehlinger U; Infanger E; Burger D; Zuber M; Langer I; Guller U; Berclaz G; Koechli OR; Schaer G; Fehr MK; Hess T; Oertli D; Bronz L; Schnarwyler B; Wight E; Uehlinger U; Infanger E; Burger D; Zuber M;
- Institution
- Department of Surgery, University Hospital Basel, Basel, Switzerland.
- Journal
- Ann Surg. 2007 Mar;245(3):452-61.
- Abstract URL
- Click here to view abstract
Next: Radiation Therapy
